GENETICS

Genetic change/disorder/disease/mutation/dysfunction from birth/embryo that is disadvantageous, Prevention-Cure with natural low cost high efficiency IUI Individual Universal Immunotherapy C-Life-IUI-CBM-SAV-SAS-SAT-SLR.

Any birth disadvantageous genetic disorder as muscular dystrophy genetic dystrophin protein dysfunction can be resolved by biologic medicine natural process copying, not by artificial collateral effect patent/monopoly price abuse alo-biology inefficient solutions from allopathic medicine.

Artificial vDNA vector-viral genetic change strategies can generate auto-immune reactions and if immune protection is suppressed, it can generate pathogen infections and other dysfunctions. Natural path Exosome mRNAs can produce proteins from structural stromal or function somatic cells.

Sirtuins can help repair embryo healthy DNA, genome/epigenome, function somatic expression of cells. Nucleus Sirtuin 1, 6, 7 proteins help repair DNA, Sirtuin 2 cytoplasm and 3,4,5 mitochondria. Changing general unhealthy embryo DNA somatic cells can create conflict with DNA of immune cells.

Individual ex-vivo cell culture new blood with same embryo genetic DNA can regenerate, reform, repair, replace, revoke cells, to correct circumstantial advantageous general species genetic regeneration decline, adding ex-vivo proteins, protein producing mRNA to supplement defects.

Embryos or Gametes, sperm/egg, from the identified genetic defect individual or couple, can receive genetic changes via Vector-Viral vDNA, Crispr-Bacteria cDNA, Nucleus nDNA change or any other DNA reform technology, or use own and/or third parties gamete selection for in-vitro fertilization.

C-Life Cubic Cell Culture Life

C-Life combines CBM, Cell Bank Medculture and IUI, Individual Universal Immunotherapy to create ex-vivo supplementation to the similar in-vivo process, but in a reduced space/time to increase efficiency and to eliminate harmful conditions including genetic deficiencies, adding efficient quantities/types.

IUI Individual Universal Immunotherapy

Immune cells are extracted from the patient and exposed to antigens or a small load of pathogens in a controlled environment outside the body. This process helps train immune cells to recognize and attack the pathogen, determining quantity/type that is most effective, given a genetic vulnerability.

These trained immune cells are then activated and expanded in number to ensure a robust response when reintroduced into the body. The activated and expanded immune cells are infused back into the patient. These cells/antibodies are now better quantified/equipped to recognize/combat the pathogen.

CBM Cell Bank Medculture

Cultivating cells/proteins ex-vivo, replicating the in-vivo defense process, can increase efficiency against genetic deficiencies, being more efficient than traditional artificial allopathic treatments that also have collateral effects. Biologic Medicine of Permanent Life is based on natural tech paradigm.

SAV Super Auto Vaccine

Ex-vivo non-Human mRNA/vDNA can produce antigens to be loaded in individual immune cells and introduced in-vivo. In-vivo non-Human mRNA vaccines can trigger immune response or trigger benign response. Human mRNA vaccines can produce Human antigens as cancer cells.

vDNA Vector Vaccines interact with Human DNA and can generate immune response or benign non-immune response confusing the immune system. The natural in-vivo immune paradigm should be preserved and replicated in-vivo and ex-vivo.

SAS Super Auto Supplement

In addition to supplementing antibodies, antigen loaded immune cells, nano mRNAs intra-skin and micro/macro molecules/proteins/cells intra-venal can replicate proven in-vivo processes ex-vivo supplementing genetic deficiencies and avoiding low efficiency, collateral effect artificial treatments.

SAT Super Auto Test

MeScope, microfluid saliva, blood, urine, mucus, sweat, tear and fecal matter can identify genetic deficiencies, proteins/antigens via photonic imaging of cell phone, accessory lenses and network HAI, Human Artificial Intelligent enlargement/analysis, complemented by mini testing in mini-laboratory.